Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-03-14

Clinical Trial Update: Multiple-Site Study to Evaluate the Therapeutic Equivalence of Permethrin Cream, 5% in the Treatment of Scabies [Phase 3]

View source ↗

Summary

Phase 3 trial assessing therapeutic equivalence of Permethrin Cream 5% for treating scabies has completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Permethrin Cream, 5% (permethrin)

Snippet

Sponsor: Encube Ethicals Pvt. Ltd. | Conditions: Scabies | Phase 3 | Status: COMPLETED | Results posted: 2019-03-14